Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (5y) (2022 - 2026)
Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.52 Bn | 35.79 Bn | 1.97 Bn |
| 2 | Zoetis | 33.53 Bn | 31.59 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.92 Bn | 21.77 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.96 Bn | 16.88 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.47 Bn | 15.15 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.76 Bn | 11.33 Bn | 785.00 Mn |
| 7 | Alkermes | 7.11 Bn | 6.60 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.53 Bn | 6.03 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 5.98 Bn | 5.23 Bn | 396.79 Mn |
| 10 | Liquidia | 5.44 Bn | 5.22 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.82% |
| Dec 31, 2025 | 45.65% |
| Sep 30, 2025 | 7.28% |
| Jun 30, 2025 | -1.60% |
| Mar 31, 2025 | -27.05% |
| Dec 31, 2024 | 1.26% |
| Sep 30, 2024 | 28.43% |
| Jun 30, 2024 | 15.07% |
| Mar 31, 2024 | -80.34% |
| Dec 31, 2023 | 47.22% |
| Sep 30, 2023 | -20.21% |
| Jun 30, 2023 | 51.13% |
| Mar 31, 2023 | -17.22% |
| Dec 31, 2022 | 7.02% |
| Sep 30, 2022 | -6.30% |
| Jun 30, 2022 | -15.06% |
| Mar 31, 2022 | -25.56% |